A Phase 1 Study of Temsirolimus in Combination With Irinotecan and Temozolomide in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2015
At a glance
- Drugs Irinotecan (Primary) ; Temozolomide (Primary) ; Temsirolimus (Primary)
- Indications CNS cancer; Glioma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2013 Planned end date changed from 1 Nov 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 14 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 May 2012 Planned End Date changed from 1 May 2011 to 1 Nov 2013 as reported by ClinicalTrials.gov.